Revenue (Annual) Chart

View Revenue (Annual) for SNN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Annual) Chart
Start Trial

Historical Revenue (Annual) Data

View and export this data back to 1980. Start Trial.
Date Value
December 31, 2025 6.178B
December 31, 2024 5.812B
December 31, 2023 5.549B
December 31, 2022 5.215B
December 31, 2021 5.212B
December 31, 2020 4.56B
December 31, 2019 5.138B
December 31, 2018 4.904B
December 31, 2017 4.765B
December 31, 2016 4.669B
December 31, 2015 4.634B
December 31, 2014 4.617B
December 31, 2013 4.351B
December 31, 2012 4.158B
December 31, 2011 4.27B
December 31, 2010 3.962B
December 31, 2009 3.772B
December 31, 2008 3.801B
December 31, 2007 3.377B
December 31, 2006 2.779B
December 31, 2005 2.548B
December 31, 2004 2.287B
December 31, 2003 1.926B
Date Value
December 31, 2002 1.626B
December 31, 2001 1.557B
December 31, 2000 1.521B
December 31, 1999 1.740B
December 31, 1998 1.740B
December 31, 1997 1.690B
December 31, 1996 1.667B
December 31, 1995 1.572B
December 31, 1994 1.454B
December 31, 1993 1.398B
December 31, 1992 1.460B
December 31, 1991 1.395B
December 31, 1990 1.296B
December 31, 1989 1.161B
December 31, 1988 1.063B
December 31, 1987 893.65M
December 31, 1986 706.01M
December 31, 1985 543.32M
December 31, 1984 497.95M
December 31, 1983 475.63M
July 31, 1982 496.55M
July 31, 1981 556.70M
July 31, 1980 478.16M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Annual) Range, Past 5 Years

View Revenue (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Annual) Benchmarks

View Revenue (Annual) Benchmarks
Start Trial
NovoCure Ltd. 655.35M
LivaNova Plc 1.388B
Polarean Imaging Plc --
Abingdon Health Plc 10.90M
Convatec Group Plc 2.439B